Lastly, DPP-4 has been reported to possess a deleterious role and potential to be used as a biomarker in respiratory diseases, such as lung cancer, asthma, and chronic obstructive pulmonary disease (COPD) [88,89,90]. This evidence concerns the gene DPP4 and chronic obstructive pulmonary disease.